Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Poll: 62% of Americans would oppose U.S. military action in Greenland - 2Seoul says sorry after unapproved drone flights into North Korea
- 3The World's Dazzling Regular Miracles
- 4The most effective method to Pick the Right Material Organization: Your Definitive Aide
- 5US healthcare spending soars to over $5 trillion in 2024
- Knesset sets special panel to fast-track Karhi’s communications reform
- Israeli media reports Iran attacking greater Tel Aviv region
- Instructions to Pick the Right Gold Speculation Procedure: Exploring the Market
- An ex-FBI agent analyzes what we learned from Savannah Guthrie's 'Today' show interview amid the search for her mother Nancy
- Why boosting production of Venezuela's 'very dense, very sloppy' oil could harm the environment
- NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
- 'No middle ground' for tackling antisemitism after Bondi Beach mass shooting, deputy FM Haskel says
- Israeli military says it hit dozens of military facilities in Tehran
- Israel reports killing another senior Iranian oil official
